We study mechanisms required for the pathogenesis of infection and cancer and discover novel compounds to inhibit these mechanisms by using a combination of enzymology, structural biology and biophysical chemistry.
We have openings for graduate and undergraduate students. Graduate students should first apply to the Ph.D. Program in Pharmaceutical Sciences at the University of Kentucky.
- The SBGrid Consortium at Harvard University publishes an article on our group.
- Congratulations to Caixia! Her manuscript on structural studies of mithramycin-DNA complexes and mithramycin interactions with FLI1-DNA complexes, a collaboration with the Rohr and Ivanov laboratories, was accepted for publication in Nucleic Acids Research.
- Congratulations to Caixia and Keith! Their manuscript on the discovery of potent inhibitors of acetyltransferase Eis that overcome resistance to kanamycin in Mycobacterium tuberculosis was accepted for publication in the ACS Chemical Biology.
- Congratulations to Stevi and Caixia! Their manuscript on dimerization and DNA binding of mithramycins was accepted for publication in the Journal of Inorganic Biochemistry.
- Congratulations to Caixia on the acceptance of her manuscript on oncogenic transcription factor FLI1 for publication in Biochemistry.
- Congratulations to Allan! His manuscript on a crystal structure of PltA halogenase from the pyoluteorin pathway was accepted for publication in the Journal of Structural Biology.
- Congratulations to Allan on his authorship on a publication on the structure and mechanism of inorganic pyrophosphatase from Mycobacteirum tuberculosis in the Journal of Structural Biology.
- Congratulations to Caixia on her authorship on a publication on a crystal structure of methyltransferase CalO6 from the calicheamicin biosynthetic pathway in BMC Structural Biology.
- Dimitri Leggas wins a highly competitive 2015 Presidential Scholarship. Only ~140 graduating high-school seniors across the US receive this award. Congratulations, Dimitri!